| DC9248 |
Olodaterol(BI-1744) hydrochloride
Featured
|
Olodaterol is a novel, long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs. |
|
| DCAPI1455 |
Olopatadine Hydrochloride |
Olopatadine Hydrochloride |
|
| DC9577 |
Olprinone (Hydrochloride)
Featured
|
Olprinone Hcl(Loprinone Hcl) is a selective phosphodiesterase 3 (PDE3) inhibitor. |
|
| DC8390 |
Oltipraz
Featured
|
Oltipraz is a potent Nrf2 activator and a potent inducer of Phase II detoxification enzymes, most notably glutathione-S-transferase (GST). Phase 3. |
|
| DC10299 |
Olumacostat glasaretil |
Olumacostat glasaretil is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC). |
|
| DC12281 |
Olutasidenib (FT-2102)
Featured
|
Olutasidenib is a highly potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 that could be used in the treatment of acute myeloid leukemia. |
|
| DC10365 |
Omadacycline (tosylate)
Featured
|
Omadacycline is novel, aminomethyl tetracycline antibiotic being developed for the treatment of community-acquired bacterial infections. |
|
| DC10324 |
Omapatrilat |
Omapatrilat is a dual inhibitor of the metalloproteases ACE and NEP with Ki values of 0.64 and 0.45 nM, respectively. |
|
| DC11335 |
Ombitasvir |
Ombitasvir is an orally bioavailable and potent inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A). |
|
| DC7023 |
Ombrabulin
Featured
|
Ombrabulin (AVE8062) hydrochloride is a synthetic derivative of CA-4-P, which inhibits growth in a large number of drug-resistant animal tumors and carcinogen-induced tumors. |
|
| DC10054 |
Ombrabulin hydrochloride
Featured
|
Ombrabulin (AVE8062) hydrochloride is a synthetic derivative of CA-4-P, which inhibits growth in a large number of drug-resistant animal tumors and carcinogen-induced tumors. |
|
| DC5195 |
Omecamtiv mecarbil (CK-1827452)
Featured
|
Omecamtivmecarbil (CK-1827452) is a specific cardiac myosinactivator and a clinical drug for left ventricular systolic heart failure. |
|
| DC9077 |
Omeprazole |
Omeprazole(Prilosec) is a proton pump inhibitor used in the treatment of dyspepsia. |
|
| DC11043 |
Omidenepag
Featured
|
Omidenepag is a potent, selective agonist human EP2 receptor with binding IC50/EC50 of 10/1.7 nM, >500-fold selectivity over EP1, EP3 and EP4 receptors; Omidenepag is the active form of Omidenepag Isopropyl (OMDI). |
|
| DC11044 |
Omidenepag Isopropyl
Featured
|
Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor; demonstrates excellent IOP-lowering activities following ocular administration in ocular normotensive monkeys, Omidenepag Isopropyl (OMDI) is a clinical candidate for the treatment of glaucoma. |
|
| DC22463 |
ON 146040 |
ON 146040 is a potent, dual PI3K/BCR-ABL inhibitor with IC50 of 14/20 nM for PI3Kα/δ , IC50 of 20 nM for BCR/ABL. |
|
| DC12164 |
ON-013100
Featured
|
ON-013100, an antineoplastic drug, acts a mitotic inhibitor that could inhibit Cyclin D1 expression. |
|
| DC22186 |
ON108110 |
ON108110 (ON-108110, ON 108110) is a novel multi-kinase inhibitor of protein kinase CK2 (CK2α1/2, IC50=3/2 nM) as well as CDK4/6 (IC50=2-24 nM). |
|
| DC9927 |
ON1231320
Featured
|
ON1231320 is a potent selective inhibitor of Polo like kinase 2 (PLK2). |
|
| DC9253 |
ON123300
Featured
|
ON123300 is a novel multiple kinase inhibitor. |
|
| DC11417 |
ONC 212
Featured
|
ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer drug and also a selective agonist of GPR132. |
|
| DC8137 |
Oncrasin 1
Featured
|
Oncrasin 1 is a proapoptotic substance. Induces abnormal nuclear aggregation of PKCι and suppressing RNA transcription. |
|
| DC9089 |
Ondansetron HCl |
Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy. |
|
| DC23492 |
ONO-3080573 |
ONO-3080573 is a potent LPA1 inhibitor with IC50 of 11 nM.. |
|
| DC10043 |
ONO4059 hydrochloride
Featured
|
ONO-4059 is a highly selective, orally bioavailable BTK inhibitor with a potency (IC50) of 2.2 nM. |
|
| DC8358 |
ONO-4059(Tirabrutinib)
Featured
|
ONO-4059 is a novel Small Molecule Dual Inhibitor Of Bruton’s Tyrosine Kinase (Btk) and Tec Kinase. |
|
| DC23689 |
ONO-6126 |
ONO-6126 is a potent and selective PDE4 inhibitor for the treatment of bronchial asthma and allergic conjunctivitis.. |
|
| DC10630 |
ONO-7300243
Featured
|
ONO-7300243 is a novel, potent LPA1(Lysophosphatidic Acid Receptor) antagonist with an IC50 of 160 nM. |
|
| DC11267 |
ONO-8590580
Featured
|
ONO-8590580 is a Novel GABAAα5 Negative Allosteric Modulator Enhances Long-Term Potentiation and Improves Cognitive Deficits in Preclinical Models. |
|
| DC23490 |
ONO-9780307 |
ONO-9780307 is a potent LPA1 inhibitor with IC50 of 27 nM.. |
|
